Enhabit Defends Medicare Advantage Strategy, Overhead Costs

On Monday, Enhabit Inc. (NYSE: EHAB) defended its strategy of taking on more Medicare Advantage (MA) revenue over the last couple of years. It did so in yet another response to AREX Capital Management, an activist investor that owns 4.9% of Enhabit shares. Enhabit and AREX Capital – which wants to replace Enhabit’s current board […]

What Makes A ‘Top Tier’ Payer In The Eyes Of A Home Health Provider

As the Centers for Medicare & Medicaid Services (CMS) cuts fee-for-service Medicare rates and Medicare Advantage (MA) penetration continues, top-tier home health companies are looking for top-tier payers to work with. Enhabit Inc. (NYSE: EHAB) considers itself a top-tier provider – regularly pointing toward its 30-day hospitalization rate, which was 20.5% below the national average […]

Enhabit Urges Shareholders To Trust Its Process, Vote Against Activist Investor’s Board Nominations

Enhabit Inc. (NYSE: EHAB) remains on the defensive against the activist investor AREX Capital Management. Last month, it provided more details around its completed strategic review, explaining the rationale behind remaining an independent company, in lieu of a merger or a sale. On Monday, it laid out its reasoning behind past struggles, its plan for […]

Payers Continue To Take Short-Sighted View Of Home Health Care

Home health providers want better rates and arrangements from Medicare Advantage (MA) plans. The plans, on the other hand, sometimes still can’t figure out what they want from providers. Some of the largest home health companies have begun to make headway with MA plans. “I think the payers are recognizing that this is not a […]

With Pressure From Activist Investor, Enhabit Reveals More Details Around Its Strategic Review

With pressure from an activist investor, Enhabit Inc. (NYSE: EHAB) has released more information surrounding its strategic review, which was completed earlier this month. Instead of a merger or sale, the Dallas-based home health and hospice company elected to remain an independent, public company. The activist investor, AREX Capital Management, previously said a sale was […]